Inhaled nitric oxide as adjunctive therapy for severe malaria: a randomized controlled trial - sprookjes - yvandenbroek - TriplyDB

Inhaled nitric oxide as adjunctive therapy for severe malaria: a randomized controlled trial

Inhaled nitric oxide as adjunctive therapy for severe malaria: a randomized controlled trial

http://www.wikidata.org/entity/Q36223174

about

Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola.Pathophysiological Mechanisms in Gaseous Therapies for Severe Malaria EPCR and Malaria Severity: The Center of a Perfect Storm.Methemoglobin and nitric oxide therapy in Ugandan children hospitalized for febrile illness: results from a prospective cohort study and randomized double-blind placebo-controlled trial.Defining Surrogate Endpoints for Clinical Trials in Severe Falciparum Malaria Endothelial activation, haemostasis and thrombosis biomarkers in Ugandan children with severe malaria participating in a clinical trial.Acute Kidney Injury Is Common in Pediatric Severe Malaria and Is Associated With Increased Mortality.Intravascular haemolysis with haemoglobinuria in a splenectomized patient with severe Plasmodium knowlesi malaria.Alterations in Systemic Extracellular Heme and Hemopexin Are Associated With Adverse Clinical Outcomes in Ugandan Children With Severe Malaria.Host Biomarkers Are Associated With Response to Therapy and Long-Term Mortality in Pediatric Severe Malaria.Systematic review of the role of angiopoietin-1 and angiopoietin-2 in Plasmodium species infections: biomarkers or therapeutic targets?miR-155 Modifies Inflammation, Endothelial Activation and Blood-Brain Barrier Dysfunction in Cerebral Malaria.Dynamic interactions of Plasmodium spp. with vascular endothelium.S-Nitrosoglutathione Reductase Deficiency Confers Improved Survival and Neurological Outcome in Experimental Cerebral Malaria.Variant surface antigens of Plasmodium falciparum and their roles in severe malaria.Do we know enough to find an adjunctive therapy for cerebral malaria in African children?Inhibition of merozoite invasion and transient de-sequestration by sevuparin in humans with Plasmodium falciparum malaria.Synthetic oleanane triterpenoids enhance blood brain barrier integrity and improve survival in experimental cerebral malaria.Inhaled nitric oxide and cognition in pediatric severe malaria: A randomized double-blind placebo controlled trial.Adjunctive therapy for severe malaria: a review and critical appraisal.Anemia was an Uncommon Complication of Severe Malaria in a High-Transmission Rural Area of Western Uganda.Chitinase-3-like 1 is a biomarker of acute kidney injury and mortality in paediatric severe malaria.

P2860

Q28076034-50A5475D-059B-4560-9B86-49FE10DEA533 Q28080030-740F811B-3BDB-49AB-8F40-351032EB85E5 Q34547050-B1FA0D2C-6580-477C-92EA-15ABB1F40210 Q36183209-CFAF4A50-25EF-4B37-8CCF-8EA8E00F159D Q36239480-2AFA1543-496A-4960-9BB9-FB259BA5DC42 Q36530522-CDDCCB07-763B-4DFE-807A-F87809B25F23 Q36900031-E715BCA7-2C9F-4BE0-9017-460BD408E49B Q37243860-B7F0A644-716F-42E7-BB32-A4C0A00FCC2A Q37279771-C422A996-9378-4A52-BAEF-0D5A3B8DAB37 Q37305512-18A7CC62-20FF-485E-BE9B-40F921E55971 Q37466271-F96FF848-812E-4145-B2C3-8C4EDBCAE0BB Q37718931-E80C49AB-C211-46CC-A376-0789DEFC0702 Q38689845-06C68E31-D70E-44E5-A736-B0B998F19F30 Q38695353-FB747F2F-B907-4F31-B44F-C8EFE9A1577B Q39365658-2CC9D964-2FDC-4658-A5F5-39C64D278EF2 Q46237821-33F04969-2460-4420-A733-811726579FFD Q46990904-5BD195AC-C87B-4982-BFE3-774B47469F8B Q47093575-A5F14BEF-0F9B-447C-85D0-D63836AFAB3F Q47647472-4275583A-4BCC-4EE2-88AF-27C88F229C1F Q47716363-E053F3F5-D0D3-49EF-AA6F-B4B346209143 Q48020246-21BDEB52-4EFD-4D72-AF8C-DE6908AC7A7F Q49962999-1FBABEE7-F4B6-43FD-8C87-AD73AEEBC86B

P2860

Inhaled nitric oxide as adjunctive therapy for severe malaria: a randomized controlled trial

http://www.wikidata.org/entity/Q36223174

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Inhaled nitric oxide as adjunc ...... a randomized controlled trial

@ast

Inhaled nitric oxide as adjunc ...... a randomized controlled trial

@en

type

label

Inhaled nitric oxide as adjunc ...... a randomized controlled trial

@ast

Inhaled nitric oxide as adjunc ...... a randomized controlled trial

@en

prefLabel

Inhaled nitric oxide as adjunc ...... a randomized controlled trial

@ast

Inhaled nitric oxide as adjunc ...... a randomized controlled trial

@en

P1433

Q36223174-7EC67A93-76D7-440D-9969-20FFF1774CAA

P1476

Q36223174-56144462-AB52-4E35-A487-23A007E5828D

P2093

Q36223174-17B111D8-C1F1-4915-ADDD-1FCE0147DBDB

Q36223174-2F0BB2EA-49CD-47E5-8DEE-FCB97F762301

Q36223174-37A32C6B-E0B4-4474-BCE3-6DC547BBB3EE

Q36223174-4EF4A7F4-EA4D-44C7-BDE8-A26B15429352

Q36223174-5E3563EC-FA4E-46DD-B47E-8D30021D97AD

Q36223174-9B5D69B9-1BC4-49FF-BEAF-97E82134BFD4

Q36223174-C8CC9B3B-2C51-4D5F-8972-81CBE4782334

Q36223174-F22EE1AF-45ED-4D3C-9099-D6A729A6CAA3

Q36223174-F392AA1B-07CC-4FAA-BAC2-B027EB32F46A

P2860

Q36223174-00C0EDC3-7730-493D-88C6-D77A7D770650

Q36223174-0A3E75DA-54BE-4A17-BCF3-55EA2286C3EF

Q36223174-1BDEAF5C-B6D9-4F9F-AF04-DF207A3DB4B7

Q36223174-3206E7C9-BC5A-423F-885B-CACBB96A3353

Q36223174-359D5863-CC55-4BCE-8C15-5D860FEB5EDA

Q36223174-416E538C-F43A-43E0-A10E-806BA16D4FE4

Q36223174-48116E20-D9F2-4B99-95CF-6B4CDBF300BE

Q36223174-4906F8BC-0D23-41D1-8DC2-032A8F9B6D97

Q36223174-4A12B49C-1EFE-44E3-8601-F9DC11D3433C

Q36223174-504ADBEE-FDFB-4C52-AFCE-207EE434BE5C

P2888

Q36223174-5E686F18-DE4C-485F-83DE-857074CF038B

P304

Q36223174-717E9B3A-1261-491A-9775-F796EE93BD2D

P31

Q36223174-43644F79-40D6-415D-9918-8AC8D7A08A8C

P356

Q36223174-22366759-877B-412B-8088-7B5A870B4E1B

P407

Q36223174-611713C6-6BC3-4849-AE7F-A7380ED7BD4B

P433

Q36223174-8BA69354-C746-4F76-ADF8-BD26606A312B

P478

Q36223174-871F9FFB-8159-4D3C-A449-20D78E08317B

P50

Q36223174-34011D80-2C44-4414-A83D-DFB45BD9C0AD

Q36223174-66BA4301-98B2-4B8A-89D0-6A47645556D7

Q36223174-7D227107-B7EA-4E75-B77E-ED5D7F864548

Q36223174-B789B8FA-A1F6-4A46-86A8-D7C938C25A95

P577

Q36223174-43CB7C53-2AD7-47CB-8E50-9F5FA0E754A4

P5875

Q36223174-128E3360-16A7-49B4-8475-395DAFD4C57D

P6179

Q36223174-0D1B4663-D083-4D10-BE1F-8305745F43B7

P698

Q36223174-D6B5E13E-54BB-400F-AAEF-13753DD41B2B

P921

Q36223174-19394B26-9532-44F2-8464-92716C20D2A6

P932

Q36223174-B443E4FE-A79D-4FE7-9053-B7E046C6FC62

P356

S12936-015-0946-2

P1433

Malaria Journal

P1476

Inhaled nitric oxide as adjunc ...... a randomized controlled trial

@en

P2093

Andrea L Conroy

http://www.w3.org/2001/XMLSchema#string

Chandy John

http://www.w3.org/2001/XMLSchema#string

Chloe McDonald

http://www.w3.org/2001/XMLSchema#string

Chris Miller

http://www.w3.org/2001/XMLSchema#string

Hani Kim

http://www.w3.org/2001/XMLSchema#string

Kevin E Thorpe

http://www.w3.org/2001/XMLSchema#string

Laura Hermann

http://www.w3.org/2001/XMLSchema#string

Sarah Higgins

http://www.w3.org/2001/XMLSchema#string

W Conrad Liles

http://www.w3.org/2001/XMLSchema#string

P2860

Global malaria mortality between 1980 and 2010: a systematic analysis

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

Nitric oxide for respiratory failure in infants born at or near term

Inhaled nitric oxide for acute hypoxemic respiratory failure in children and adults

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial

Combinations of host biomarkers predict mortality among Ugandan children with severe malaria: a retrospective case-control study

Inhaled nitric oxide reduces endothelial activation and parasite accumulation in the brain, and enhances survival in experimental cerebral malaria

The prevention and treatment of missing data in clinical trials

Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria.

Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children

P2888

s12936-015-0946-2

P304

421

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12936-015-0946-2

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Michael T Hawkes

Sophie Namasopo

P577

2015-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283308417

http://www.w3.org/2001/XMLSchema#string

P6179

1043117770

http://www.w3.org/2001/XMLSchema#string

P698

26510464

http://www.w3.org/2001/XMLSchema#string

P921

P932

4625637

http://www.w3.org/2001/XMLSchema#string